Dipeptidyl-Peptidase-IV Inhibitors, Imigliptin and Alogliptin, Improve Beta-Cell Function in Type 2 Diabetes.
Saved in:
| Title: | Dipeptidyl-Peptidase-IV Inhibitors, Imigliptin and Alogliptin, Improve Beta-Cell Function in Type 2 Diabetes. |
|---|---|
| Authors: | Liu X; Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China.; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China., Liu Y; Clinical Pharmacology Research Center, Peking Union Medical College Hospital and Chinese Academy of Medical Sciences, Beijing, China.; Department of Pharmacology, College of Pharmacy, Inner Mongolia Medical University, Hohhot, China., Liu H; Clinical Pharmacology Research Center, Peking Union Medical College Hospital and Chinese Academy of Medical Sciences, Beijing, China., Li H; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.; Center of Clinical Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing, China., Yang J; Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China., Hu P; Clinical Pharmacology Research Center, Peking Union Medical College Hospital and Chinese Academy of Medical Sciences, Beijing, China., Xiao X; Department of Endocrinology, Key Laboratory of Endocrinology of National Health Commission, Peking Union Medical College Hospital and Chinese Academy of Medical Sciences, Beijing, China., Liu D; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.; Center of Clinical Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing, China. |
| Source: | Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2021 Sep 20; Vol. 12, pp. 694390. Date of Electronic Publication: 2021 Sep 20 (Print Publication: 2021). |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
